Table 1 Sociodemographic and Clinical Characteristics of the Study Sample (n = 146)
Characteristic | Frequency (%) or mean (SD) | Median (IQ 25–75) |
|---|---|---|
Sex | ||
Male/female | 78 (53.4%)/68 (46.6%) | |
Hospitalized | ||
Yes/no | 64 (43.8%)/82 (56.2%) | |
Education (years) | 6.81 (4.17) | 6 (0; 17) |
65.16 (14.04) | 66 (58; 75) | |
Karnofsky performance status scale (KPS) | 59.18 (21.38) | 50 (40; 80) |
Score ≤ 60/score > 61 | 42.77 (10.74)/80.79 (9.03) | 50 (20; 60)/80 (70; 100) |
Score NPS (0–10), most of the time in the last 24 h | ||
Cancer (yes/no) | 4.4 (3.61)/4.74 (3.99) | 5 (0; 10)/6 (0; 10) |
Score on NPS (0–10) after use pain medication | ||
Cancer (yes/no) | 2 (2.83)/2.21 (2.69) | 0 (0; 10)/0 (0; 8) |
Primary cancer clinical diagnosis | Frequency (%) | |
|---|---|---|
Palliative care patients without cancer | 44 (30) | |
Lung carcinoma | 15 (10) | |
Head and neck cancer | 15 (10) | |
Melanoma | 4 (3) | |
Breast cancer | 9 (6) | |
Adenocarcinoma | 6 (4) | |
Esophagus cancer | 9 (6) | |
Prostate carcinoma | 13 (9) | |
Bowel cancer | 1 (1) | |
Colorectal cancer | 5 (3) | |
Stomach cancer | 7 (5) | |
Lymphoma | 1 (1) | |
Hepatoma | 2 (1) | |
Endometrial cancer | 4 (3) | |
Kidney cancer | 2 (1) | |
Bladder cancer | 2 (1) | |
Diagnosis to be confirmed | 7 (5) |